• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Nano Dimension Ltd. (Amendment)

    11/3/23 5:30:56 PM ET
    $NNDM
    Electrical Products
    Technology
    Get the next $NNDM alert in real time by email
    SC 13D/A 1 d578646dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D/A

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 4)*

     

     

    Nano Dimension Ltd.

    (Name of Issuer)

    Ordinary Shares, NIS 5.00 par value

    (Title of Class of Securities)

    63008G203**

    (CUSIP Number)

    Bruce R. Winson

    Anson Funds Management LP

    16000 Dallas Parkway, Suite 800

    Dallas, TX 75248

    (214) 866-0202

    With a copy to:

    Eleazer Klein, Esq.

    Adriana Schwartz, Esq.

    Schulte Roth & Zabel LLP

    919 Third Avenue

    New York, New York 10022

    (212)756-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    November 1, 2023

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    **

    There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 63008G203 has been assigned to the American Depositary Shares (“ADSs”) of the Issuer, which are quoted on the NASDAQ Stock Market LLC under the symbol “NNDM.” Each ADS represents one Ordinary Share.

     

     

     


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 2 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Anson Funds Management LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     IA, PN


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 3 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Anson Management GP LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     HC, OO


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 4 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Bruce R. Winson

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States Citizen

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     HC, IN


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 5 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Anson Advisors Inc.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☒ ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ontario, Canada

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     FI, CO


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 6 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Amin Nathoo

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Canadian Citizen

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     HC, IN


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 7 of 10 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Moez Kassam

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS (See Instructions)

     

     AF

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Canadian Citizen

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7   

     SOLE VOTING POWER

     

        8  

     SHARED VOTING POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

        9  

     SOLE DISPOSITIVE POWER

     

       10  

     SHARED DISPOSITIVE POWER

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     20,391,213 ordinary shares (represented by 20,391,213 ADSs)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     8.7%

    14  

     TYPE OF REPORTING PERSON (See Instructions)

     

     HC, IN


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 8 of 10 Pages

     

    This Amendment No. 4 (“Amendment No. 4”) is being filed by Anson Funds Management LP (the “Investment Entity”), Anson Management GP LLC, Mr. Bruce R. Winson, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam (collectively, the “Reporting Persons”) with respect to the ordinary shares, par value NIS 5.00 (the “Ordinary Shares” or the “Shares”) of Nano Dimension Ltd., a corporation incorporated under the laws of Israel (the “Issuer”). This Amendment No. 4 amends and supplements Amendment No. 3 filed with the Securities and Exchange Commission (the “SEC”) on October 24, 2023 (“Amendment No. 3”), Amendment No. 2 filed with the SEC on June 23, 2023 (“Amendment No. 2”), Amendment No. 1 filed with the SEC on May 1, 20213 (“Amendment No. 1”) and the Schedule 13D filed with the SEC on March 10, 2023 (the “Original Schedule 13D”, and collectively with Amendment No. 1, Amendment No. 2, Amendment No. 3 and this Amendment No. 4, the “Schedule 13D”). Except as specifically provided herein, this Amendment No. 4 does not modify any of the information previously reported in the Schedule 13D. Information in response to each item shall be deemed to be incorporated by reference in all other items. Capitalized terms used but not defined in this Amendment No. 4 shall have the meanings ascribed to such terms in the Schedule 13D.

     

    Item 3.

    Source and Amount of Funds or Other Considerations

    Item 3 of the Schedule 13D is amended and restated as follows:

    The ADSs representing the Ordinary Shares reported herein as being beneficially owned by the Reporting Persons were purchased using working capital of the Funds. An aggregate of approximately $53,598,776 (excluding brokerage commissions) was used to purchase ADSs representing Ordinary Shares reported as beneficially owned by the Reporting Persons in this Schedule 13D. Such securities were acquired through open market purchases.

     

    Item 5.

    Interest in Securities of the Issuer

    Items 5(a)-(c) of the Schedule 13D are amended and restated as follows:

    (a) See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D are calculated based upon an aggregate of 235,106,980 shares outstanding as of October 18, 2023, which is (i) 11,755,349 Ordinary Shares, representing 5% of the outstanding Ordinary Shares as of October 18, 2023, as reported in Exhibit 99.3 to the Issuer’s Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 18, 2023, multiplied by (ii) twenty.

    (b) See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

    (c) The transactions by the Reporting Persons in the ADSs of the Issuer during the past sixty (60) days are set forth in Schedule A. All such transactions were carried out in open market transactions.


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 9 of 10 Pages

     

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 3, 2023

     

    ANSON FUNDS MANAGEMENT LP
    By:   Anson Management GP LLC, its general partner
    By:  

    /s/ Bruce R. Winson

      Bruce R. Winson
      Manager

     

    ANSON MANAGEMENT GP LLC
    By:  

    /s/ Bruce R. Winson

      Bruce R. Winson
      Manager
     

    /s/ Bruce R. Winson

      Bruce R. Winson

     

    ANSON ADVISORS INC.
    By:  

    /s/ Amin Nathoo

      Amin Nathoo
      Director

     

    By:  

    /s/ Moez Kassam

      Moez Kassam
      Director
     

    /s/ Amin Nathoo

      Amin Nathoo
     

    /s/ Moez Kassam

      Moez Kassam


    CUSIP No. 63008G203    SCHEDULE 13D/A    Page 10 of 10 Pages

     

    SCHEDULE A

    TRANSACTIONS OF THE ISSUER

    SINCE THE FILING OF THE ORIGINAL SCHEDULE 13D

    The following table sets forth all transactions in the ADSs in the past (60) days by the Reporting Persons. All such transactions were effected in the open market through brokers and the price per share excludes commissions. These ADSs were purchased or sold in multiple transactions at prices indicated in the column Price Per ADS ($). Where a price range is provided in the column Price Range ($), the price reported in that row’s Price Per ADS ($) column is a weighted average price. These ADSs were purchased or sold in multiple transactions at prices between the price ranges indicated in the Price Range ($) column. The Reporting Persons will undertake to provide to the staff of the SEC, upon request, full information regarding the number of ADSs purchased or sold at each separate price.

     

    Trade Date

      

    ADSs Purchased (Sold)

      

    Price per ADS ($)

      

    Price Range ($)

     

    10/19/2023

       1,000,000    2.7312   

    10/20/2023

       200,000    2.7734   

    10/23/2023

       392,000    2.7949   

    10/24/2023

       360,000    2.8525   

    10/25/2023

       542,000    2.7353   

    10/26/2023

       149,000    2.6968   

    10/27/2023

       300,000    2.6287   

    10/27/2023

       773,600 via option exercise    2.5000 exercise price   

    10/30/2023

       303,000    2.5737   

    10/31/2023

       70,000    2.6317   

    11/1/2023

       303,000    2.564   

    11/2/2023

       3,800    2.6100   

    11/3/2023

       20,650    2.5600   

    11/3/2023

       100 via option exercise    2.5000 exercise price   
    Get the next $NNDM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNDM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NNDM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Stehlin David covered exercise/tax liability with 24,971 units of Ordinary Shares, decreasing direct ownership by 3% to 737,032 units (SEC Form 4) to satisfy withholding obligation

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    7/14/26 4:15:13 PM ET
    $NNDM
    Electrical Products
    Technology

    Chief Executive Officer Stehlin David covered exercise/tax liability with 19,841 units of Ordinary Shares, decreasing direct ownership by 3% to 762,003 units (SEC Form 4) to satisfy tax liability

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/10/26 4:15:18 PM ET
    $NNDM
    Electrical Products
    Technology

    Director Sriubas Andrew was granted 160,000 units of Ordinary Shares, increasing direct ownership by 400% to 200,015 units (SEC Form 4)

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/4/26 4:01:49 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors

    WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the "July EGM"), Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") and Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson") today jointly announced a settlement agreement. Under the terms of the agreement executed on July 17, the July EGM will be cancelled. Messrs. Pons, Rosensweig, Sriubas and Stehlin (collectively, the "Departing Directors") resigned from the Board and all their positions at Nano. The directors nominated by Murchinson for the July EGM — Messrs. Fruc

    7/20/26 8:30:00 AM ET
    $NNDM
    Electrical Products
    Technology

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $NNDM
    SEC Filings

    View All

    SEC Form 8-K filed by Nano Dimension Ltd.

    8-K - Nano Dimension Ltd. (0001643303) (Filer)

    7/21/26 4:05:15 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form 144 filed by Nano Dimension Ltd.

    144 - Nano Dimension Ltd. (0001643303) (Subject)

    7/14/26 7:54:34 AM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form DEFA14A filed by Nano Dimension Ltd.

    DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)

    7/10/26 9:15:18 AM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

    WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer ("CEO"), effective immediately. The Company’s Board of Directors (the "Board") has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Company’s strategic priorities and opportunities moving forward. Phillip Borenstein, Chairman of the Board, commented, "On behalf of myself and the entire Board of Directors, we are pleased to appoint

    7/21/26 4:05:00 PM ET
    $NNDM
    $LFWD
    Electrical Products
    Technology
    Industrial Specialties
    Health Care

    QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

    Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the "Board") appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (NASDAQ:NNDM), where she led multidisciplinary teams spanning materials, formulations, chemistry, physics, process engineering, mechanics, software, hardware, and electronics. She also co-authored peer-reviewed IEEE research o

    7/17/26 8:30:00 AM ET
    $IINN
    $NNDM
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Financials

    Live finance-specific insights

    View All

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company

    It Is Time to Talk About Nano Dimension Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today announced it will host an investor conference call to discuss the Company's so-called strategic review, Chairman Bob Pons' role in the "review process," and other concerns related to the Company's business and corporate governance. After eight months of limited progress and minimal communication from Nano regarding its strategic review, Murchinson believes shareholders deserve a constructive

    5/26/26 5:00:00 PM ET
    $NNDM
    Electrical Products
    Technology

    $NNDM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    11/13/24 11:31:24 AM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/23/24 8:21:43 PM ET
    $NNDM
    Electrical Products
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    10/11/24 4:47:45 PM ET
    $NNDM
    Electrical Products
    Technology